PhantomFX has officially confirmed its immunity to the upcoming US tariffs on certain import categories, signaling strategic confidence amid ongoing trade tensions. The company, a prominent visual effects studio, emphasizes its robust domestic and international operations, with offices across India, North America, and Europe.
Key Highlights
The firm asserts that its existing operations and ongoing projects safeguard it against the impact of the US tariff proposals, which target specific categories like pharmaceuticals and heavy machinery.
As a trusted, globally recognized VFX studio, PhantomFX continuously expands its cross-border collaborations and high-value contracts, reinforcing its market resilience.
The company’s recent initiatives include securing new high-value contracts worth 72 Crores for FY25-26 and raising ₹59.99 Crore via QIP for global expansion strategies.
Implication for Investors
PhantomFX’s stance on immunity provides a positive outlook for stakeholders, underscoring its strategic adaptability and financial stability despite potential global trade disruptions.
The company’s expansion plans and consistent revenue growth demonstrate resilience against adverse tariffs, positioning it as a reliable player in the visual effects industry.
Sources: Simply Wall, Screener, NSE, Business Standard, SimpliWall, Outlook Money